The Effect of Natural Carbonated Mineral Water Consumption on Gastrointestinal Transit and on Gut Microbiota in Subjects With Functional Constipation: A Randomized, Placebo-Controlled Pilot Trial

Last updated: May 11, 2022
Sponsor: Universidade Nova de Lisboa
Overall Status: Active - Recruiting

Phase

N/A

Condition

Constipation

Treatment

N/A

Clinical Study ID

NCT05375487
MineralWaterGut
  • Ages 18-70
  • All Genders

Study Summary

Functional constipation (FC) is a common condition associated with aging, lower socioeconomic status, low physical activity and also with reduced fibre, water and magnesium intakes. Different studies have reported a positive association between the intake of hyper-mineral water containing a high content of bicarbonate, calcium, or magnesium, and the improve of the gastrointestinal transit. There is evidence that magnesium and sulphate, both individually, have a laxative action. However, the impact of other minerals is scarce. It has been described different mechanisms explaining how gut microbiota influence the gastrointestinal transit. Specifically, in FC patients, it is important to understand the particularities of their gut microbiota and understand whether the intake of hyper-mineral water, a natural source of minerals, can modify positively the gut microbiota. The aim of the present randomized placebo-controlled pilot trial is to evaluate, for the first time, the effect of the carbonated mineral water consumption in the gastrointestinal transit and in the gut microbiota of subjects with FC.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age between 18 to 70
  • Having Functional Constipation diagnosis criteria, according to the Rome IV criteria
  • Not using any laxative drug for 3 days before screening visit
  • Drinking 1.0 ± 0.5 L of water per day
  • Accept and sign the consent

Exclusion

Exclusion Criteria:

  • Treatment or disease (current or past) likely to interfere with evaluation of thestudy parameters
  • Taking antibiotics in the 3 months preceding the recruitment visit
  • Taking supplements and any food enriched or presented containing bacteria or yeastslikely to have an effect on the gastrointestinal tract, particularly on intestinaltransit, digestive comfort, gas production, the occurrence of abdominal pain in the 30days preceding the recruitment visit (these products will also be banned during thestudy period)
  • Subject having an alcohol consumption of more than 3 glasses of wine a day, or 2glasses of beer a day, or 1 glass of hard liquor a day
  • Subject having a coffee consumption greater than 5 cups per day
  • Subject with constipation attributable to an organic or anatomical cause (Hirschsprung's disease, hypothyroidism, mental deficiency, psychiatric illness,neurological abnormalities, history of operation of the colon or anus, colorectalcancer, anemia, etc.)
  • Subject with a history of current gastrointestinal pathology or disorder such asduodenal ulcer, chronic colitis, or chronic inflammatory disease of thegastrointestinal tract (Crohn's disease, ulcerative colitis), celiac disease orsyndrome irritable bowel
  • Subject having a history of operation of the digestive tract
  • Subject having undergone surgery in the two months preceding the recruitment visit
  • Subject having undergone bariatric surgery
  • History of renal disease (renal insufficiency etc.) or cardiovascular disease (cardiacinsufficiency...), respiratory disease, neural disease
  • Having participated in a weight loss program (with a 5-10% weight) loss in the last 3months prior to the recruitment visit
  • Body mass index > 35 kg/ m2
  • Taking supplements of magnesium, vitamins, or other minerals during the study period
  • Intake of other carbonated mineral waters beyond the given water, during the studyperiod.
  • Pregnancy
  • Participation in another clinical trial during the last 30 days prior to therecruitment visit

Study Design

Total Participants: 60
Study Start date:
May 01, 2022
Estimated Completion Date:
December 31, 2022

Connect with a study center

  • NOVA Medical School | Faculdade de Ciências Médicas da Universidade NOVA

    Lisbon, 1169-056
    Portugal

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.